Companies A-Z

Coherus Oncology, Inc.

To enroll a patient into Coherus Solutions please visit enroll.coherussolutions.com/enroll.

Patient Support Services Overview 

Enrollment support provided by Case Managers

• Product-specific benefit verification 
• Co-pay enrollment 
• Patient Assistance Program (PAP)
• Coverage, coding, and reimbursement support

Patient support through customized programs 

The Coherus Solutions™ Co-Pay Savings Program 

This program may reduce out-of-pockets costs for commercially insured eligible* patients. 

Eligible* patients may pay: 

• As little as $0 out-of-pocket for each dose of LOQTORZI 

Covered costs may include co-pay, coinsurance, and deductibles for the drug. Program does not cover costs associated with drug administration. The co-pay program has a 180-day lookback period. 

To enroll your patient, please go to CoherusSolutions.com and enroll.

*Eligibility Criteria 

• Be prescribed LOQTORZI for a medically appropriate purpose within 180 days of program enrollment.
• Have commercial (private or non-governmental) health insurance that covers the medication costs of LOQTORZI.
• Be over the age of 18 years old and a US resident.
• Not covered by any federal, state, or government-funded health care program, such as Medicare, Medicare Advantage, Medicare Part D, Veterans Affairs, Department of Defense, or TRICARE.
• Not seek reimbursement from any third-party, including payers, charitable foundations, or flexible spending account (FSAs) or health care savings accounts (HSAs) for all or any part of the benefit received by Coherus through this program.
• Other restrictions apply, see full Terms & Conditions.
• It is not valid for cash paying patients or where prohibited by law.
• LOQTORZI Co-Pay Savings Program is subject to change or discontinuation without notice. This is not health insurance. 

The LOQTORZI Solutions™ Patient Assistance Program 

Patients who have been prescribed LOQTORZI with no insurance or who are underinsured* may be eligible for patient assistance through the Patient Assistance Program (PAP).

*Underinsured means the patient does not have coverage for LOQTORZI. 

To enroll your patient, please go to CoherusSolutions.com and login.

Patient Eligibility Criteria

• Be either: (a) uninsured; (b) underinsured* 
• Be a U.S. resident and must physically reside in the U.S. 
• Have an adjusted annual household income of ≤ 500% of Federal Poverty Level (FPL).
• Be under the care of a U.S. licensed provider, and receive LOQTORZI in an established practice located in the U.S. incident to the prescribing physician’s professional services in the outpatient setting. 
• Diagnosis and dosing are consistent with FDA-approved indication for LOQTORZI, or provider believes LOQTORZI is medically necessary based on the patient’s diagnosis.
• Not have any other financial support options.
• Complete and sign consent form and, when applicable, provide income documentation.
• If eligible, the Patient Assistance Program only covers the costs of LOQTORZI and does not cover any administration or office visit costs. 
• Restrictions may apply and not valid where prohibited by law. Coherus may revise or terminate this program without notice at any time for any reason. 

Independent Foundation Support 

Coherus Solutions™ may also be able to help your patients find financial support through charitable foundations. Case Managers can research alternative coverage options for your patients. 

Access support provided by Field Reimbursement Managers (FRMs) 

• Billing, coding, & coverage overview 
• Reimbursement health check 
• Electronic Data Interchange (EDI) billing support 
• Coherus Solutions™ services review 
• Claim and PA denial & appeal support 

Please feel free to contact Coherus Solutions™ at 877-260-5190 with any questions. Hours of operation are 9:00 AM – 7:00 PM ET Monday through Friday. 

For additional information please visit CoherusSolutions.com. 

US-CMB-0051.2  09/2025 

Oncology-related products: Loqtorzi^® (toripalimab-tpzil) injection, Udenyca^® (pegfilgrastim-cbqv) injection

Reimbursement Assistance

Coherus Solutions™

Reimbursement support provided by patient access specialists, include:

• Product-specific benefit verification

• Coverage, coding, and reimbursement

• Prior authorization services

• Product replacement support.

For reimbursement assistance, contact your field reimbursement manager (CoherusSolutions.com) or call 1.877.260.5190, Monday through Friday, 8:00 AM to 8:00 PM EST.

Co-Pay Card/Out-Of-Pocket Cost Assistance

Coherus Solutions™ Co-Pay Assistance Program

Coherus Solutions offers a co-pay assistance program that covers out-of-pocket expenses related to LOQTORZI for commercially insured patients. Eligible patients qualify for $0 out-of-pocket costs for each LOQTORZI dose. The program has a 180-day lookback period. The maximum annual benefit is $15,000 per enrollment period. No physical co-pay card is required.

To be eligible for the Co-Pay Assistance Program, patients:

• Must be prescribed LOQTORZI for a medically appropriate use.

• Must have commercial health insurance that covers the medication costs of LOQTORZI.

• Must not be covered by any federal-, state-, or government-funded healthcare program, such as Medicare, Medicaid, Medicare Advantage, Medicare Part D, Veterans Affairs, Department of Defense, or TriCare.

• Must not seek reimbursement amount received from Coherus from any third-party payers, including flexible spending accounts or health care savings accounts.

To enroll, go online.

For assistance with co-pay claims reimbursement, call the program at 1.877.260.5190, Monday through Friday, 8:00 AM to 8:00 PM EST.

The co-pay program only covers the costs of LOQTORZI and does not cover any administration or office visit costs. Restrictions may apply and not valid where prohibited by law. Coherus may revise or terminate this program without notice at any time.

Patient Assistance Program

Coherus Solutions™ Patient Assistance Program

Patients with no insurance may be eligible for financial support for LOQTORZI through the patient assistance program. Patient eligibility criteria:

• Uninsured, functionally underinsured, or Medicare patients that demonstrate financial hardship and cannot afford their cost-sharing obligation.

• Must meet all eligibility requirements to qualify.

• United States resident and must physically reside in the U.S. or U.S. territory.

• Be under the care of a U.S. licensed provider with an established practice located in the U.S.

• Do not have any other financial support options.

• Diagnosis and dosing must be consistent with FDA-approved prescribing information for LOQTORZI.

• Adjusted annual household income of less than or equal to 500 percent of federal poverty level.

• Must receive treatment in an outpatient setting by the physician or physician office.

Underinsured includes patients with health insurance that does not cover a toripalimab-tpzil product (biosimilar or reference product).

Health care providers requesting more than 6 refills by the program for the same patient will be required to provide written attestation on business letterhead affirming continued program necessity.

If a patient received LOQTORZI within the past 6 months, they may be eligible for retro patient assistance.

To enroll, fax the completed enrollment form to 1.877.260.5190.

For more information, visit the program website or call 1.877.260.5190, Monday through Friday, 8:00 AM to 8:00 PM EST.